The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma

Maria-Li LUNG; Arthur-Kwok-Leung CHEUNG; Josephine-Mun-Yee KO; Hong-Lok LUNG; Yue CHENG; Wei DAI.
Chinese Journal of Cancer ; (12): 556-568, 2014.
Artículo en Inglés | WPRIM | ID: wpr-349628

Documentos relacionados

  1. EBV and MS: The evidence is growing stronger.
  2. The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.
  3. The immune escape mechanism of nasopharyngeal carcinoma.
  4. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis.
  5. The immunology of Epstein-Barr virus-induced disease.
  6. Blocking EBV-driven lymphomageneis metabolism.
  7. Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
  8. Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.
  9. How does Epstein-Barr virus trigger MS?
  10. [Clinical pathological and genetic mutation characteristics of conjunctival lymphoepithelial carcinoma].